Loading...
XLONBVC
Market cap99mUSD
Dec 24, Last price  
18.27GBP
1D
-4.84%
1Q
-8.65%
Jan 2017
-1.91%
Name

Batm Advanced Communications Ltd

Chart & Performance

D1W1MN
XLON:BVC chart
P/E
—
P/S
81.38
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
1.46%
Rev. gr., 5y
0.54%
Revenues
123m
+5.78%
41,218,00056,514,00073,472,00096,952,000134,462,080135,394,355120,577,688127,633,570107,774,000114,155,000109,247,00097,096,00090,404,000107,137,000119,561,000123,396,000183,566,000140,038,000116,123,000122,830,000
Net income
-193k
L
-12,781,000-3,423,0006,445,00019,874,00024,204,66120,516,8441,698,7840713,000-4,513,000-3,176,000-13,250,000-1,070,000233,000585,0003,917,0009,793,00014,340,0001,556,000-193,000
CFO
5m
P
-1,924,000-3,213,0003,776,00012,644,0009,093,33520,233,88612,481,7603,137,7273,206,000634,000-5,282,000-2,247,000915,00056,0002,607,0007,166,00018,459,0005,592,000-2,784,0005,009,000
Dividend
Dec 09, 20210.74 GBP/sh
Earnings
Mar 05, 2025

Profile

BATM Advanced Communications Ltd., together with its subsidiaries, develops, produces, and markets real-time technologies in Israel, the United States, and Europe. It operates through two segments, Networking and Cyber, and Bio-Medical. The Networking and Cyber segment is involved in the research and development, production, and marketing of data communication products, including network function virtualization, edge computing, carrier ethernet and MPLS access solutions, cyber network monitoring, and network encryption. This segment also offers software services, such as training and technical support, laboratory service and maintenance; and construction contracts. The Bio-Medical segment offers molecular biology diagnostics; and solutions to treat pathogenic and medical waste in laboratories and hospitals, as well as for pharmaceutical manufacturing plants and agricultural applications. This segment also administers testing services; and distributes diagnostic equipment and medical supplies of various brands. The company was incorporated in 1992 and is headquartered in Hod Hasharon, Israel.
URL
https://www.batm.com/
IPO date
Aug 12, 1996
Employees
949
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
122,830
5.78%
116,123
-17.08%
140,038
-23.71%
Cost of revenue
123,482
115,417
128,223
Unusual Expense (Income)
NOPBT
(652)
706
11,815
NOPBT Margin
0.61%
8.44%
Operating Taxes
839
339
9,337
Tax Rate
48.02%
79.03%
NOPAT
(1,491)
367
2,478
Net income
(193)
-112.40%
1,556
-89.15%
14,340
46.43%
Dividends
(4,300)
Dividend yield
3.55%
Proceeds from repurchase of equity
(1,325)
58
BB yield
1.09%
-0.02%
Debt
Debt current
5,106
4,219
3,820
Long-term debt
8,458
11,500
13,758
Deferred revenue
621
Other long-term liabilities
4,047
4,009
3,888
Net debt
(46,314)
(36,212)
(61,447)
Cash flow
Cash from operating activities
5,009
(2,784)
5,592
CAPEX
(2,404)
(4,468)
(3,289)
Cash from investing activities
(6,120)
(16,342)
15,069
Cash from financing activities
(2,160)
(7,050)
(4,937)
FCF
224
(13,347)
10,769
Balance
Cash
40,764
44,167
67,763
Long term investments
19,114
7,764
11,262
Excess cash
53,736
46,125
72,023
Stockholders' equity
(249,490)
(279,325)
(281,857)
Invested Capital
382,057
406,494
414,236
ROIC
0.09%
0.59%
ROCE
0.55%
8.91%
EV
Common stock shares outstanding
436,818
442,357
444,268
Price
0.20
-26.09%
0.27
-67.42%
0.84
-9.57%
Market cap
88,456
-27.02%
121,206
-67.56%
373,629
-9.53%
EV
71,099
116,740
328,742
EBITDA
4,524
5,597
17,079
EV/EBITDA
15.72
20.86
19.25
Interest
1,374
2,011
911
Interest/NOPBT
284.84%
7.71%